Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/10/2010 | US20100143297 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
06/10/2010 | US20100143296 Podophyllotoxin inhibitors of topoisomerase ii |
06/10/2010 | US20100143295 Quinazoline inhibitors of egfr tyrosine kinase |
06/10/2010 | US20100143293 T cell activation |
06/10/2010 | US20100143292 Il-21 variants |
06/10/2010 | US20100143291 Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells |
06/10/2010 | US20100143290 Monoclonal antibodies to human thymidine kinase to treat cancer |
06/10/2010 | US20100143289 Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
06/10/2010 | US20100143288 Human granulocyte-colony stimulating factor isoforms |
06/10/2010 | US20100143262 Method for Identifying Allergenic Proteins And Peptides |
06/10/2010 | US20100143243 Frozen compositions and methods for piercing a substrate |
06/10/2010 | US20100143242 Delivery system for therapy comprising hollow seeds, and the method of use thereof |
06/10/2010 | DE4419264B4 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections |
06/10/2010 | DE102008060549A1 Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung Drug-peptide construct for extracellular accumulation |
06/10/2010 | CA2776949A1 Methods and compositions for treating p.acnes |
06/10/2010 | CA2745919A1 Compositions and methods relating to mir-31 |
06/10/2010 | CA2745795A1 Compositions for potentiating apoposis signals in tumour cells |
06/10/2010 | CA2745746A1 Microrna-based methods and compositions for the diagnosis and treatment of ovarian cancer |
06/10/2010 | CA2745694A1 Formulations of guanylate cyclase c agonists and methods of use |
06/10/2010 | CA2745527A1 Leptin and leptin analog conjugates and uses thereof |
06/10/2010 | CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
06/10/2010 | CA2745411A1 Inhalant containing modified superoxide dismutase |
06/10/2010 | CA2745240A1 Methods and uses involving heme binding protein 1 |
06/10/2010 | CA2745205A1 Glutamyl trna synthetase (gts) fragments |
06/10/2010 | CA2745111A1 Modulation of olfml-3 mediated angiogenesis |
06/10/2010 | CA2741302A1 Polypeptide for treating or preventing adhesions |
06/10/2010 | CA2740347A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms |
06/09/2010 | EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases |
06/09/2010 | EP2194130A1 Cytokine ZCYTO18 |
06/09/2010 | EP2194124A1 Protein kinase c peptide modulators of angiogenesis |
06/09/2010 | EP2194064A1 FGF-21 fusion proteins |
06/09/2010 | EP2194062A1 Cyclic heptapeptide and use of the same |
06/09/2010 | EP2194061A1 HC-Toxin as means for treating advanced stage neuroblastoma |
06/09/2010 | EP2193809A1 Albumin-free factor VIII formulations |
06/09/2010 | EP2193805A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
06/09/2010 | EP2193804A2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
06/09/2010 | EP2193801A2 Caspase-8 and inflammation, infection and wound healing |
06/09/2010 | EP2193800A1 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly |
06/09/2010 | EP2193799A1 Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly |
06/09/2010 | EP2193798A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
06/09/2010 | EP2193791A1 The treatment of respiratory diseases |
06/09/2010 | EP2193200A1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof |
06/09/2010 | EP2193142A1 Compositions and methods of using proislet peptides and analogs thereof |
06/09/2010 | EP2192955A1 A modulator of nrg1 for treatment of respiratory disorders |
06/09/2010 | EP2192915A1 Therapeutic uses of peptides ysaypdsvpmms and wmnstgftkvcgappc |
06/09/2010 | EP2192914A1 Polymeric linkers containing pyridyl disulfide moieties |
06/09/2010 | EP2192907A2 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
06/09/2010 | EP2192889A2 Cosmetic methods and compositions for repairing human skin |
06/09/2010 | EP2192835A1 Treatment of lung cancer |
06/09/2010 | EP2192834A1 Protein kinase c- inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation |
06/09/2010 | EP2004215B1 Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
06/09/2010 | EP1653990B1 Use of polypeptides of the cupredoxin family in cancer therapy |
06/09/2010 | EP1558649B1 Peptid modulating caspase activation |
06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
06/09/2010 | EP1335981B1 18480 human protein kinase molecules and uses therefor |
06/09/2010 | EP1308165B1 Skin wound healing promoters |
06/09/2010 | EP1062226B1 High affinity nucleic acid ligands of the complement system c5 protein |
06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
06/09/2010 | CN1986568B INF-alpha expression relevant protein and its coding gene |
06/09/2010 | CN1922324B Bacterial virulence factors and uses thereof |
06/09/2010 | CN1899601B Antibiotic peptide Babu plaster and its preparing method |
06/09/2010 | CN1874784B Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
06/09/2010 | CN1849076B Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases |
06/09/2010 | CN1826099B Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
06/09/2010 | CN1819839B Immune-adjusting compound and relating method thereof |
06/09/2010 | CN1744909B Orally administered peptides synergize statin activity |
06/09/2010 | CN101730740A Methods for production of recombinant plasminogen and plasmin polypeptides |
06/09/2010 | CN101730711A preprocalcitonin antigen t epitopes |
06/09/2010 | CN101730710A Vegf-d mutants and their use |
06/09/2010 | CN101730545A Compounds and methods for the treatment of renal disease |
06/09/2010 | CN101730540A Wound healing compositions containing keratin biomaterials |
06/09/2010 | CN101730539A Fibrin gel for controlled release of tgf-beta and uses thereof |
06/09/2010 | CN101730538A Imaging and therapy of virus-associated tumors |
06/09/2010 | CN101730523A Glp-1-fc fusion protein formulation |
06/09/2010 | CN101730481A Food compositions |
06/09/2010 | CN101724632A Bullfrog skin active peptide, gene and application thereof in pharmacy |
06/09/2010 | CN101724631A Preparation of functional area of sea purse blood vessel growth inhibition factor 1 and use of the functional area of sea purse blood vessel growth inhibition factor 1 in medicaments for preventing and curing tumors |
06/09/2010 | CN101724612A Human epididymis expression sperm binding protein HEL-128 as well as coding gene and application thereof |
06/09/2010 | CN101724606A Porcine circoviruses, vaccines and diagnostic reagents |
06/09/2010 | CN101724075A Remodeling and glycoconjugation of peptides |
06/09/2010 | CN101724067A Human epididymis expression sperm binding protein HEL-122 as well as coding gene and application thereof |
06/09/2010 | CN101724066A Mimic polypeptides of myeloid differentiation protein-2 and application thereof |
06/09/2010 | CN101724065A Human epididymal expression sperm binding protein HEL-202 as well as encoding gene and application thereof |
06/09/2010 | CN101724064A Human epididymis expression sperm binding protein HEL-192 and encoding gene and application thereof |
06/09/2010 | CN101724063A Human epididymis expression sperm binding protein HEL-178 and encoding gene and application thereof |
06/09/2010 | CN101724062A Human epididymis expression sperm binding protein HEL-172 as well as encoding gene and application thereof |
06/09/2010 | CN101724061A Human epididymis expression sperm binding protein HEL-81, encoding gene and application thereof |
06/09/2010 | CN101724060A Human epididymis expression sperm binding protein HEL-90, encoding gene and application thereof |
06/09/2010 | CN101724059A Human epididymis expression sperm binding protein HEL-72, encoding gene and application thereof |
06/09/2010 | CN101724058A Human epididymis expression sperm binding protein HEL-48, encoding gene and application thereof |
06/09/2010 | CN101724055A Human epididymal expression sperm binding protein HEL-215 as well as encoding gene and application thereof |
06/09/2010 | CN101724054A Human epididymal expression sperm binding protein HEL-213 as well as encoding gene and application thereof |
06/09/2010 | CN101724053A Human epididymis expression sperm binding protein HEL-78, encoding gene and application thereof |
06/09/2010 | CN101724052A Human epididymis expression sperm binding protein HEL-65, encoding gene and application thereof |
06/09/2010 | CN101724051A Human epididymis expression sperm binding protein HEL-59, encoding gene and application thereof |
06/09/2010 | CN101724050A Human epididymal expression sperm binding protein HEL-214 as well as encoding gene and application thereof |
06/09/2010 | CN101724049A Human epididymal expression sperm binding protein HEL-207 as well as encoding gene and application thereof |
06/09/2010 | CN101724048A Human epididymal expression sperm binding protein HEL-200 as well as encoding gene and application thereof |
06/09/2010 | CN101724047A Human epididymis expression sperm binding protein HEL-190 and encoding gene and application thereof |
06/09/2010 | CN101724046A Human epididymis expression sperm binding protein HEL-18 and encoding gene and application thereof |